Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

ECB. 2015; 4(12): 539-542


ADENOSINE DEAMINASE AND ITS ISOENZYMES IN ASCITES WITH DIFFERENT ETIOLOGIES

Mohamed Ahmed Abdelmoaty, Ahmed Mohamed Bogdady.




Abstract

Adenosine deaminase (ADA) activity increased in certain clinical conditions including tuberculosis and bacterial infections. In this study,
the ADA isoenzymes patterns are assayed in ascites of different etiologies. Ninety two patients with ascites were selected and investigated
to determine the cause of ascites. Total ADA and its isoenzymes are assayed spectophotometerically beside polyacrylamide gel
electrophoretically. The total ADA in ascitic fluid secondary to parainfection in case of TB, abdominal cancer and liver cirrhosis is found to
be 34.5±11.1, 87.6±23.6, 32.7±10.1 and 28.5±7.3 U L-1
respectivly. The ADA1m was 24.5±11.1, 4.3±1.9, 2.8±2.2 and 10.1±3.3 U L-1
.
ADA1c was 7.8±3, 16.5±6.2, 4.7±1.3 and 10.1± .3 U L-1
respectivly. ADA2 was 2.2±3.9, 65.9±33.5, 26.2±6.2 and 3.3±9.7 U L-1

respectively. Hence it is concluded that total ADA above 41 U L-1
and ADA2 above 32 U L-1
in ascetic fluid have high sensitivity value in
TB peritonitis. The ascitic fluid ADA1m/ADA more than 50 % has high specificty value in parainfective peritonitis. Total ascitic ADA50 % have high specificity in abdominal cancer

Key words: ADA; tuberculosis; liver cirrhosis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.